These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 2650999)

  • 1. Epidermal growth factor receptor proto-oncogene. Structure, evolution of properties of receptor mutants.
    Schlessinger J
    Contrib Gynecol Obstet; 1989; 17():44-8. PubMed ID: 2650999
    [No Abstract]   [Full Text] [Related]  

  • 2. Two independent amplification events on chromosome 7 in glioma: amplification of the epidermal growth factor receptor gene and amplification of the oncogene MET.
    Wullich B; Sattler HP; Fischer U; Meese E
    Anticancer Res; 1994; 14(2A):577-9. PubMed ID: 8017863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neu-oncogene: signal transduction pathways, transformation mechanisms and evolving therapies.
    Dougall WC; Qian X; Peterson NC; Miller MJ; Samanta A; Greene MI
    Oncogene; 1994 Aug; 9(8):2109-23. PubMed ID: 7913542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Transcriptional control of the protooncogenes--human EGF receptor gene and c-Ha-ras 1 gene].
    Ishii S
    Tanpakushitsu Kakusan Koso; 1986 Jul; 31(8):681-92. PubMed ID: 3538192
    [No Abstract]   [Full Text] [Related]  

  • 5. A mutant epidermal growth factor receptor targeted to lung epithelium inhibits asbestos-induced proliferation and proto-oncogene expression.
    Manning CB; Cummins AB; Jung MW; Berlanger I; Timblin CR; Palmer C; Taatjes DJ; Hemenway D; Vacek P; Mossman BT
    Cancer Res; 2002 Aug; 62(15):4169-75. PubMed ID: 12154012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single point mutations in the SH2 domain impair the transforming potential of vav and fail to activate proto-vav.
    Katzav S
    Oncogene; 1993 Jul; 8(7):1757-63. PubMed ID: 8510922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of the uterine epidermal growth factor receptor by estrogen.
    Stancel GM; Chiapetta C; Gardner RM; Kirkland JL; Lin TH; Lingham RB; Loose-Mitchell DS; Mukku VR; Orengo CA
    Prog Clin Biol Res; 1990; 322():213-26. PubMed ID: 2406734
    [No Abstract]   [Full Text] [Related]  

  • 8. Analysis of structure and activation of some receptor-type tyrosine kinase oncogenes.
    Shibuya M; Matsushime H; Yamazaki H; Wang LH; Fukui Y; Ueyama Y; Tamaoki N
    Princess Takamatsu Symp; 1986; 17():195-202. PubMed ID: 3455414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A point mutation in the neu oncogene mimics ligand induction of receptor aggregation.
    Weiner DB; Liu J; Cohen JA; Williams WV; Greene MI
    Nature; 1989 May; 339(6221):230-1. PubMed ID: 2654648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The EGF receptor: structure, regulation and potential role in malignancy.
    Thompson DM; Gill GN
    Cancer Surv; 1985; 4(4):767-88. PubMed ID: 2824044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the neu oncogene product in cell transformation and normal development.
    Kokai Y; Wada T; Myers JN; Brown VI; Dobashi K; Cohen J; Hamuro J; Weiner DB; Greene MI
    Princess Takamatsu Symp; 1988; 19():45-57. PubMed ID: 2908355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The erB-related growth factor receptors.
    Yamamoto T; Semba K; Toyoshima K
    Horiz Biochem Biophys; 1986; 8():571-609. PubMed ID: 3019864
    [No Abstract]   [Full Text] [Related]  

  • 13. [Epidermal growth receptors].
    Wu P; Tong TJ
    Sheng Li Ke Xue Jin Zhan; 1990 Apr; 21(2):134-8. PubMed ID: 2205913
    [No Abstract]   [Full Text] [Related]  

  • 14. Oncogenes and uterine function.
    Stancel GM; Baker VV; Hyder SM; Kirkland JL; Loose-Mitchell DS
    Oxf Rev Reprod Biol; 1993; 15():1-42. PubMed ID: 8336974
    [No Abstract]   [Full Text] [Related]  

  • 15. Oncogenes related to head and neck cancer.
    Issing WJ; Wustrow TP; Heppt WJ
    Anticancer Res; 1993; 13(6B):2541-51. PubMed ID: 8135494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neu and its ligands: from an oncogene to neural factors.
    Peles E; Yarden Y
    Bioessays; 1993 Dec; 15(12):815-24. PubMed ID: 7908191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The erbB gene and the EGF receptor.
    Martin GS
    Cancer Surv; 1986; 5(2):199-219. PubMed ID: 2877733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amplification of epidermal growth factor receptor gene but no evidence of ras mutations in primary human esophageal cancers.
    Hollstein MC; Smits AM; Galiana C; Yamasaki H; Bos JL; Mandard A; Partensky C; Montesano R
    Cancer Res; 1988 Sep; 48(18):5119-23. PubMed ID: 3044581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenes and tumour suppressor genes in breast cancer.
    Eccles MR; Phipps RF
    Br J Hosp Med; 1993 Nov 3-16; 50(9):529-36. PubMed ID: 7904528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered gene expression in drug-resistant human breast cancer cells.
    Wosikowski K; Schuurhuis D; Kops GJ; Saceda M; Bates SE
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2405-14. PubMed ID: 9815641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.